Literature DB >> 30091372

Psychotherapeutic interventions for chronic pain: Evidence, rationale, and advantages.

Muhammad Hassan Majeed1, Ali Ahsan Ali2, Donna M Sudak3.   

Abstract

BACKGROUND: Long-term use of opioids to treat chronic pain incurs serious risks for the individual-including misuse, abuse, addiction, overdose and death-as well as creating economic, social, and cultural impacts on society as a whole. Chronic pain and substance use disorders are often co-morbid with other medical problems and at the present time, primary care clinicians serve most of this population. Primary care clinicians would benefit from having alternatives to opioids to employ in treating such patients.
METHOD: We electronically searched different medical databases for studies evaluating the effect of nonpharmacological treatments for chronic pain. We describe alternative approaches for the treatment of chronic pain and cite studies that provide substantial evidence in favor of the use of these treatments.
RESULTS: Cognitive behavioral therapy, acceptance and commitment therapy, and mindfulness-based programs have well-documented effectiveness for the treatment of chronic nonmalignant pain. Integration of such behavioral health therapies into primary care settings may optimize health resources and improve treatment outcomes.
CONCLUSION: Evidence-based psychotherapy for chronic pain has established efficacy and safety and improves quality of life and physical and emotional functioning. Such interventions may be used as an alternative or adjunct to pharmacological management. Chronic opioid use should be reserved for individuals undergoing active cancer treatment, palliative care, or end-of-life care.

Entities:  

Keywords:  acceptance and commitment therapy; chronic pain; cognitive behavioral therapy; mindfulness-based therapies; opioid abuse. behavioral health and primary care integration

Mesh:

Year:  2018        PMID: 30091372     DOI: 10.1177/0091217418791447

Source DB:  PubMed          Journal:  Int J Psychiatry Med        ISSN: 0091-2174            Impact factor:   1.210


  8 in total

Review 1.  Pharmacological Treatment of Pain in Osteoarthritis: A Descriptive Review.

Authors:  Muhammad Hassan Majeed; Syed Ali Amir Sherazi; Douglas Bacon; Zahid H Bajwa
Journal:  Curr Rheumatol Rep       Date:  2018-11-21       Impact factor: 4.592

Review 2.  Ketamine Assisted Psychotherapy: A Systematic Narrative Review of the Literature.

Authors:  Sandra J Drozdz; Akash Goel; Matthew W McGarr; Joel Katz; Paul Ritvo; Gabriella F Mattina; Venkat Bhat; Calvin Diep; Karim S Ladha
Journal:  J Pain Res       Date:  2022-06-15       Impact factor: 2.832

3.  Commentary on Socias et al. (2018): Clinical research perspectives on cannabis use in opioid agonist treatment.

Authors:  Christine Timko; Michael A Cucciare
Journal:  Addiction       Date:  2018-09-24       Impact factor: 6.526

Review 4.  A Review of the Pharmacological Management of Chronic Pain in Patients with Heart Failure.

Authors:  Muhammad Hassan Majeed; Ali Ahsan Ali; Hafiza Ayesha Khalil; Douglas Bacon; Hafiz Muhammad Imran
Journal:  Innov Clin Neurosci       Date:  2019-11-01

5.  Quality of Life and Mental Distress in Patients with Chronic Low Back Pain: A Cross-Sectional Study.

Authors:  Dijana Hnatešen; Roman Pavić; Ivan Radoš; Iva Dimitrijević; Dino Budrovac; Maja Čebohin; Ivana Gusar
Journal:  Int J Environ Res Public Health       Date:  2022-08-26       Impact factor: 4.614

6.  Bringing chronic-pain care to rural veterans: A telehealth pilot program description.

Authors:  Lisa H Glynn; Jessica A Chen; Timothy C Dawson; Hannah Gelman; Steven B Zeliadt
Journal:  Psychol Serv       Date:  2020-01-16

7.  Mindfulness-Based Meditation Versus Progressive Relaxation Meditation: Impact on Chronic Pain in Older Female Patients With Diabetic Neuropathy.

Authors:  Nadia Hussain; Amira S A Said
Journal:  J Evid Based Integr Med       Date:  2019 Jan-Dec

8.  Childhood Trauma, Emotion Regulation, and Pain in Individuals With Alcohol Use Disorder.

Authors:  Justyna Zaorska; Maciej Kopera; Elisa M Trucco; Hubert Suszek; Paweł Kobyliński; Andrzej Jakubczyk
Journal:  Front Psychiatry       Date:  2020-10-30       Impact factor: 4.157

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.